Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

NCT04643977 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Facial Rejuvenation

Interventions

DEVICE: mARG-01-17 (mesohyal AGRIBENONE)

Sponsor

Mesoestetic Pharma Group S.L.